Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Italy Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20034
20043
20053
20063
20073
20083
20091
20101
20122
20143
20161
20173
20183
20191
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated6
Unknown status3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi10
Boehringer Ingelheim3
Daiichi Sankyo3
Bayer2
Biosense Webster, Inc.2
Bristol-Myers Squibb2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Population Health Research Institute2
Anthos Therapeutics, Inc.1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation43
Atrial Flutter5
Stroke5
Arrhythmias, Cardiac3
Heart Diseases3
Heart Failure3
Cardiovascular Diseases2
Acute Coronary Syndrome1
Atherosclerosis1
Basal Ganglia Hemorrhage1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.